MedPath
HSA Product

PERAZODIN 75 TABLET 75 mg

Product approved by Health Sciences Authority (SG)

Basic Information

PERAZODIN 75 TABLET 75 mg

TABLET, SUGAR COATED

Regulatory Information

SIN00470P

April 27, 1988

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XB01AC07

Company Information

REMEDICA LTD

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Active Ingredients

DIPYRIDAMOLE

Strength: 75 mg

Detailed Information

Contraindications

**Contraindications** Hypersensitivity to the active substance(s) or to any of the excipients listed in section List of excipients – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_. In case of rare hereditary conditions that may be incompatible with an excipient of the product (please refer to section Warnings and Precautions – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_) the use of the product is contraindicated.

Indication Information

**Indications** An adjunct to oral anti-coagulation for prophylaxis of thrombo-embolism associated with prosthetic heart valves.

© Copyright 2025. All Rights Reserved by MedPath